Clarissa Baldotto

5.3k total citations
37 papers, 816 citations indexed

About

Clarissa Baldotto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Clarissa Baldotto has authored 37 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Clarissa Baldotto's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Lung Cancer Research Studies (7 papers). Clarissa Baldotto is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Lung Cancer Research Studies (7 papers). Clarissa Baldotto collaborates with scholars based in Brazil, United States and Canada. Clarissa Baldotto's co-authors include Tomás Reinert, Mauro Zukin, Luiz H. Araujo, Carlos Gil Ferreira, Carlos H. Barrios, I. A. Small, Fernando Meton de Alencar Câmara Vieira, Ronaldo de Albuquerque Ribeiro, Rogério Lilenbaum and Fábio Franke and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal Of Pathology.

In The Last Decade

Clarissa Baldotto

34 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clarissa Baldotto Brazil 12 465 395 163 142 66 37 816
Anna Ceribelli Italy 15 449 1.0× 577 1.5× 159 1.0× 132 0.9× 112 1.7× 35 1.0k
Maria Alice Franzoi France 16 332 0.7× 568 1.4× 155 1.0× 167 1.2× 39 0.6× 51 868
Nicolò Borsellino Italy 18 277 0.6× 561 1.4× 215 1.3× 176 1.2× 94 1.4× 64 868
Nandini Menon India 13 234 0.5× 256 0.6× 103 0.6× 88 0.6× 79 1.2× 134 582
Andreas Polychronis United Kingdom 13 339 0.7× 613 1.6× 280 1.7× 126 0.9× 54 0.8× 33 1.1k
Concetta Elisa Onesti Italy 16 287 0.6× 465 1.2× 334 2.0× 255 1.8× 97 1.5× 58 937
Dipesh Uprety United States 15 377 0.8× 484 1.2× 313 1.9× 128 0.9× 74 1.1× 71 1.0k
Olga Nigro Italy 11 168 0.4× 340 0.9× 173 1.1× 99 0.7× 57 0.9× 41 643
César Sánchez Chile 14 180 0.4× 425 1.1× 267 1.6× 208 1.5× 53 0.8× 81 779
Rafał Stec Poland 18 303 0.7× 445 1.1× 377 2.3× 211 1.5× 110 1.7× 61 926

Countries citing papers authored by Clarissa Baldotto

Since Specialization
Citations

This map shows the geographic impact of Clarissa Baldotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarissa Baldotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarissa Baldotto more than expected).

Fields of papers citing papers by Clarissa Baldotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarissa Baldotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarissa Baldotto. The network helps show where Clarissa Baldotto may publish in the future.

Co-authorship network of co-authors of Clarissa Baldotto

This figure shows the co-authorship network connecting the top 25 collaborators of Clarissa Baldotto. A scholar is included among the top collaborators of Clarissa Baldotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarissa Baldotto. Clarissa Baldotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zukin, Mauro, et al.. (2025). Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and ROS1-Gene Rearrangement: A Case Report. SHILAP Revista de lepidopterología. 21(CP). 1 indexed citations
2.
Florez, Narjust, Nicole R. LeBoeuf, Julia Rotow, et al.. (2025). Mitigation and management of adverse events associated with amivantamab therapy. The Oncologist. 30(7).
3.
Zalis, Mariano, Mauro Zukin, Vladmir Cláudio Cordeiro de Lima, et al.. (2023). EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing. JCO Global Oncology. 9(9). e2200426–e2200426. 4 indexed citations
4.
Marchi, Pedro De, Gilberto de Castro, Clarissa Baldotto, et al.. (2022). Non–Small-Cell Lung Cancer With CNS Metastasis: Disparities From a Real-World Analysis (GBOT-LACOG 0417). JCO Global Oncology. 8(8). e2100333–e2100333. 4 indexed citations
5.
Ferreira, Carlos Gil, Fábio Ynoe de Moraes, Clarissa Baldotto, et al.. (2022). Real-World Evidence of Health Outcomes Related to Lung Stereotactic Body Radiation Therapy in Brazil. JCO Global Oncology. 8(8). e2200061–e2200061.
6.
Baldotto, Clarissa, et al.. (2022). Role of Stereotactic Radiation Therapy in Operable and Inoperable Early-Stage Non-small Cell Lung Cancer. Current Treatment Options in Oncology. 23(9). 1185–1200. 6 indexed citations
7.
Araujo, Luiz H., et al.. (2021). Patient-Centered Outcomes in Non-Small-Cell Lung Cancer: A Real-World Perspective. Future Oncology. 17(14). 1721–1733. 4 indexed citations
8.
Baldotto, Clarissa, Clarissa Mathias, Heloísa de Andrade Carvalho, et al.. (2020). Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group. Clinics. 75. e2060–e2060. 11 indexed citations
9.
Cronemberger, Eduardo, Clarissa Baldotto, Pedro De Marchi, et al.. (2020). Real-World Molecular Testing and Treatment Patterns in Brazilian Patients with Newly Diagnosed Locally Advanced or Metastatic NSCLC. Clinics. 75. e1777–e1777. 6 indexed citations
10.
Araujo, Luiz H., Carlos Gil Ferreira, Clarissa Baldotto, et al.. (2020). Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice. Future Oncology. 17(2). 205–213. 3 indexed citations
11.
Araujo, Luiz H., Clarissa Baldotto, Gilberto de Castro, et al.. (2018). Lung cancer in Brazil. Jornal Brasileiro de Pneumologia. 44(1). 55–64. 64 indexed citations
12.
Lima, Vladmir Cláudio Cordeiro de, Clarissa Baldotto, Carlos H. Barrios, et al.. (2018). Stage III Non–Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort. Journal of Global Oncology. 4(4). 1–11. 4 indexed citations
13.
Baldotto, Clarissa, Eduardo Cronemberger, Pedro De Marchi, et al.. (2018). P23 Stage IIIb NSCLC and Curative Intention Treatment: Difficulties and Disparities in Brazil. Journal of Thoracic Oncology. 13(9). S169–S170. 1 indexed citations
14.
Cronemberger, Eduardo, Clarissa Baldotto, Pedro De Marchi, et al.. (2018). P3.01-12 EGFR Mutation and Targeted Therapies: Difficulties and Disparities in Access to NSCLC Treatment in Brazil. Journal of Thoracic Oncology. 13(10). S871–S872. 1 indexed citations
15.
Mahase, Sean S., Pieter Wesseling, William P. J. Leenders, et al.. (2017). Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas. American Journal Of Pathology. 187(5). 940–953. 75 indexed citations
16.
Mak, Kimberley S., A.C.M. van Bommel, Caleb Stowell, et al.. (2015). Defining a Standard Set of Patient Centered Outcomes for Patients With Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). E403–E403. 1 indexed citations
17.
Ramlau, Rodryg, В. А. Горбунова, Tudor–Eliade Ciuleanu, et al.. (2012). Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial. Journal of Clinical Oncology. 30(29). 3640–3647. 135 indexed citations
18.
Novello, Silvia, Rodryg Ramlau, В. А. Горбунова, et al.. (2011). AFLIBERCEPT IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC): FINAL RESULTS OF A MULTINATIONAL PLACEBO-CONTROLLED PHASE III TRIAL (EFC10261-VITAL). 13 indexed citations
19.
Thuler, Luiz Cláudio Santos, et al.. (2009). Validation of the Portuguese version of Functional Assessment of Cancer Therapy-Fatigue (FACT-F) in Brazilian cancer patients. Supportive Care in Cancer. 18(4). 481–490. 46 indexed citations
20.
Baldotto, Clarissa, et al.. (2002). Estresse Mental e Sistema Cardiovascular. Arquivos Brasileiros de Cardiologia. 78(5). 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Ceribelli Breakdown of academic impact, for papers by Maria Alice Franzoi Breakdown of academic impact, for papers by Nicolò Borsellino Breakdown of academic impact, for papers by Nandini Menon Breakdown of academic impact, for papers by Andreas Polychronis Breakdown of academic impact, for papers by Concetta Elisa Onesti Breakdown of academic impact, for papers by Dipesh Uprety Breakdown of academic impact, for papers by Olga Nigro Breakdown of academic impact, for papers by César Sánchez Breakdown of academic impact, for papers by Rafał Stec
Rankless by CCL
2026